Our broad arsenal of services and solutions now spans the entire value chain. By expanding the methodologies of MarketRx, a highly respected firm acquired in 2007, our offerings now include: Consulting and insights, Modeling and analysis & Reporting and research. We can guide you in using the latest business analytics tools to add incremental value, drive positive operational outcomes and deliver results that are both definitive and measurable. Our dedicated team of 600+ associates is experienced in developing analytics across major industries. In fact, Fortune 500 companies in manufacturing, banking and financial services, life sciences and other sectors are already among our clients.
This is a FREE LISTING on PMHUB
Below are full profiles from other companies in related areas
We are a fully integrated agency that is 100% dedicated to creating standout communications in healthcare. Our success starts by strategically aligning promotion, medical education and PR across the product…
Advertising, Branding, Clinical Research, Conference/meetings/events, Creative and design, Digital communications, Management consultancies, Market access, Market research, Marketing consultancies, Medical communications, Medical education, Patient support and adherence, Public relations, Regulatory affairs
MDNT is a native Digital and Omnichannel agency focused solely on the healthcare, pharma, and life science industries. We’re highly experienced, no nonesense, and very good at what we do.
Onyx Health is a healthcare communications and PR agency based in the North East of England, but with a national and international reach. As we understand the healthcare market and…
OPEN Health brings together deep scientific knowledge, global understanding, and broad specialist expertise to support our clients in improving health outcomes and patient wellbeing.
Sciterion is an award winning specialist healthcare communications consultancy within the Havas Health network of companies. We exist to make a positive contribution to patient care. Real world experience of…
Company Details
Latest Content from PMHub
White Papers and Resources | February 9, 2016 | Inizio
Quantitative Director Duncan Munro explores the benefits of using patient level prescribing decisions.There is no “one size fits all” approach to conducting demand assessments. The best studies utilise a methodology...
White Papers and Resources | February 9, 2016 | Inizio
PMR invited US President Harriet Kozak to submit her predictions for 2016
White Papers and Resources | February 9, 2016 | Inizio
Research Partnership exhibited and presented a paper at the Pharmaceutical Market Research Conference last week in Parsippany, NJ.Representing Research Partnership were US President Harriet Kozak and Director Phil Rosenberg.Harriet presented the paper...
White Papers and Resources | February 9, 2016 | Inizio
Research Partnership is delighted to announce the promotion of Nicole Bender Moreira to Associate Director in recognition of the contribution she has made to the growing success of our Singapore...
White Papers and Resources | February 9, 2016 | Inizio
We are delighted to welcome Marianne Jaeger as Associate Director to our London headquarters
White Papers and Resources | February 9, 2016 | Inizio
The need to understand the patient as a key stakeholder is now recognized by pharma across the globe.
White Papers and Resources | February 9, 2016 | Inizio
Research Partnership has extended its healthcare research and consulting offering to include storytelling deliverables with the hire of multi-media graphic designer Amanda Brent at the company’s London headquarters. Working with...
White Papers and Resources | February 9, 2016 | Say Communications
Our team’s motivations behind cycling on two static bikes for 282 miles - the equivalent of London to Paris, to raise money for British Dupuytren’s Society. Please donate!
Press Releases | February 5, 2016 | Lucid Group Communications Limited
Lucid Group kick off 2016 with six new employees
White Papers and Resources | February 3, 2016 | Blue Latitude Health
Consultant David Cooney from Blue Latitude Health talks us through what this progress in genomics means for pharma in 2016.